About Nellix
Nellix is a company based in Palo Alto (United States) founded in 1994 was acquired by Endologix in October 2010. Nellix has raised $18.2 million across 3 funding rounds from investors including Endologix, Incept BioSystems and EW Healthcare Partners. Nellix operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
- Headquarter Palo Alto, United States
- SectorsHealthcare
- Website nellix.com
- Social LinkedIn
- Acquired by Endologix (Oct 2010)
- Legal Name Nellix Inc
Funding Insights of Nellix
Nellix has successfully raised a total of $18.2M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.2M
- Total Rounds 3
- Last Round Series B — $11.7M
- Investors Count 3
All 3 funding rounds of Nellix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | $11.7M | Series B | – | – | – |
| Mar 2008 | $6.5M | Series A | – | – | |
| Jun 2000 | – | Unspecified | – | – |
4 investors in total: 4 institutional.
Investors in Nellix
Nellix has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Endologix, Incept BioSystems and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Medical innovations are accelerated from concept to commercialization by Incept. | – | inceptllc.com | Bedford, USA | |
IVF technologies for embryo and oocyte culture are provided. | 2005 | inceptbio.com | Ann Arbor, United States | |
Minimally invasive treatments for aortic disorders are developed and manufactured. | 1992 | endologix.com | Irvine, United States |
Investor details for Nellix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nellix
4 dated milestones of Nellix across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Nellix is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $11.7M.
- Exit Acquired by Endologix.
Competitors of Nellix
Nellix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | – | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | |
| endoronmedical.com | 2019 | Kfar Saba, Israel | $15M | – | Endovascular fixation devices for cardiovascular stent grafts are manufactured. | |
| trivascular.com | 1998 | Santa Rosa, United States | $260.95M | 307 | Designs and manufactures for endovascular aortic repair equipment | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | – | Endovascular devices for aortic aneurysms are developed. | |
| aptusendo.com | 2002 | Sunnyvale, United States | $70M | 63 | Endograft anchoring systems for aortic aneurysms are developed. | |
| remonmedical.com | 1997 | Caesarea, Israel | $26M | – | Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics. | |
| endovastec.com | 2012 | Shanghai, China | – | – | Medical devices for treating aortic diseases are developed. | |
| emblok.com | 2013 | Kalamazoo, United States | $19.75M | – | Embolic protection devices are developed for TAVR procedures. | |
| jotec.com | 2000 | Hechingen, Germany | – | 451 | Stents and Grafts for Aortic and Peripheral arterial disease |
Detailed competitors of Nellix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Nellix
10 companies that operate in the same segment as Nellix (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nellix
Nellix was founded in 1994 and raised its 1st funding round 6 years after it was founded.
Nellix is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Nellix is a funded company, having raised a total of $18.2M across 3 funding rounds to date.
Nellix was founded in 1994 in Palo Alto, United States, within the medical device sector. A specialized endograft and low-profile delivery system have been developed to enable treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. These devices support expanded indications for minimally invasive procedures, addressing aneurysms through endovascular methods. Operations focus on innovation in vascular treatments for clinical applications.
Nellix's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Nellix has 4 investors. Key investors include Endologix, Incept BioSystems, EW Healthcare Partners, and Incept.
Nellix operates through Nellix Inc.
Yes. Nellix was acquired by Endologix in October 2010.